Peptency Academy · Compound
Kisspeptin-10 (metastin 45-54)
PubChem title: Kisspeptin-10. Catalog chemistry record: name Kisspeptin-10, also known as Metastin (45-54), sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, length 10.1 PubChem CID 252402972 Peptency catalog chemistry record, Kisspeptin-10 Kisspeptins of 54, 14 and 13 amino acids were isolated from human placenta as natural agonists of the orphan receptor GPR54, and they share an RF-amide C terminus. Source sentence
PubMed title: "The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54." Measured: isolation of kisspeptins from human placenta as ligands of GPR54, with receptor binding and signalling in cells.3 J Biol Chem 2001 PubChem records kisspeptin-10 under CID 25240297: formula C63H83N17O14, about 1302.4 Da, CAS 374675-21-5. Source sentence
Title: Kisspeptin-10; MolecularFormula: C63H83N17O14; MolecularWeight: 1302.4; CAS: 374675-21-51 PubChem CID 25240297
Research at a glance
- Most human model studied
- No primary study mapped
- Studies reviewed
- None mapped yet
- Registered trials
- 0
- EMA
- No authorisation found
- WADA
- Named in a prohibited class
Regulatory content shown for: EU and UK.
Peptide, 10 residues, C-terminal amide
- Catalog recordKisspeptin-1010 residuesabout 1302.4 DaSource sentence
Title: Kisspeptin-10; MolecularFormula: C63H83N17O14; MolecularWeight: 1302.4; CAS: 374675-21-5
1 PubChem CID 25240297
Known, not known, contested
Known
- The formula computed from the catalog sequence, C63H83N17O14, matches the formula PubChem records, and PubChem confirms the CAS number 374675-21-5 for CID 25240297. Source sentence
Catalog chemistry record cross check (5 Oct 2026): formulaFromSequence C63H83N17O14; PubChem formula C63H83N17O14; casConfirmedByPubChem true.
1 PubChem CID 252402972 Peptency catalog chemistry record, Kisspeptin-10 - A 2001 study in Nature identified the peptide encoded by the KiSS-1 gene as the ligand of an orphan G-protein-coupled receptor and measured receptor activation. Source sentence
PubMed title: "Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor." Measured: identified the KiSS-1 gene product peptide as the ligand of an orphan G-protein-coupled receptor and measured receptor activation.
4 Nature 2001 - A 2001 study cloned the human receptor AXOR12 (GPR54) and measured its activation by peptides derived from KiSS-1. Source sentence
PubMed title: "AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1." Measured: cloned the human receptor AXOR12 (GPR54) and showed its activation by KiSS-1 derived peptides.
5 J Biol Chem 2001 - A 2003 genetic study in a human family and in mice linked the GPR54 gene to the onset of puberty. Source sentence
PubMed title: "The GPR54 gene as a regulator of puberty." Measured: genetic study in a human family and in mice linking GPR54 to the onset of puberty.
6 N Engl J Med 2003
Not known
- Neither Drugs@FDA nor the EMA medicines data listed a kisspeptin or metastin medicine on 5 Oct 2026. Source sentence
openFDA Drugs@FDA lookup of the names kisspeptin, metastin: 0 applications. EMA medicines data lookup of the name kisspeptin: 0 procedures.
7 openFDA Drugs@FDA query for kisspeptin and metastin, 5 October 20268 EMA medicines data, 5 October 2026 - Of the 333 PubMed records matching kisspeptin-10 on 5 Oct 2026, this page reads 4. The other records are not summarised here. Source sentence
PubMed record count for the query: 333; records read for this page: 4 (receptor discovery and receptor genetics).
9 PubMed search for Kisspeptin-10, 5 October 2026
Contested
Nothing listed yet.
Chemistry: Kisspeptin-10 as PubChem CID 25240297 records it
- Sequence
YNWNSFGLRF- Length
- 10 residues
- Modifications
- C-terminal amide (Phe10-NH2)
- Formula
- C63H83N17O14
- Average mass
- 1302.4 Da
- CAS
- 374675-21-5
- PubChem CID
- 25240297
- Synonyms
- Metastin (45-54)
- Salt form
- No salt form stated in the record
Sequence
YNWNSFGLRF
Published literature
- On 5 Oct 2026 PubMed held 333 records matching Kisspeptin-10 by title and abstract, of which 12 carry the clinical trial publication type and 14 the review type. This page reads 4 of them. Source sentence
PubMed record count for the query ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab] OR "kisspeptin10"[tiab] OR "metastin 45-54"[tiab]): 333; with clinical trial[pt]: 12; with review[pt]: 14.
9 PubMed search for Kisspeptin-10, 5 October 2026
Studies
In vitro or ex vivoJ Biol Chem 2001
Isolation of kisspeptins from human placenta as ligands of GPR54, with receptor binding and signalling in cells.
- Design
- Receptor biology
- Population or model
- human placenta extract and receptor expressing cells
- Molecule
- Kisspeptins of 54, 14 and 13 amino acids related form
In vitro or ex vivoNature 2001
Identified the KiSS-1 gene product peptide as the ligand of an orphan G-protein-coupled receptor and measured receptor activation.
- Design
- Receptor biology
- Population or model
- orphan G-protein-coupled receptor in cells
- Molecule
- KiSS-1 gene product peptide related form
In vitro or ex vivoJ Biol Chem 2001
Cloned the human receptor AXOR12 (GPR54) and showed its activation by KiSS-1 derived peptides.
- Design
- Receptor biology
- Population or model
- cloned human receptor AXOR12 (GPR54)
- Molecule
- KiSS-1 derived peptides related form
Human, uncontrolledN Engl J Med 2003
Genetic study in a human family and in mice linking GPR54 to the onset of puberty.
- Design
- Human genetics and animal study
- Population or model
- a human family and mice
- Molecule
- The GPR54 gene, not a peptide different molecule
Receptor discovery and genetics studies
- Receptor studies from 2001 isolated kisspeptins from human placenta, identified the KiSS-1 gene product peptide as a receptor ligand, and cloned the human receptor AXOR12 (GPR54). Source sentence
Measured per the PubMed records: isolation of kisspeptins from human placenta; identification of the KiSS-1 peptide as ligand of an orphan G-protein-coupled receptor; cloning of AXOR12 (GPR54) and its activation by KiSS-1 derived peptides.
3 J Biol Chem 20014 Nature 20015 J Biol Chem 2001 - A 2003 study in a human family and in mice examined the GPR54 gene in relation to the onset of puberty. Source sentence
Measured: genetic study in a human family and in mice linking GPR54 to the onset of puberty.
6 N Engl J Med 2003
Status matrix
EMA
No authorisation found 8 EMA medicines data, 5 October 2026No centrally authorised procedure in the EMA medicines data names kisspeptin
MHRA
No record found 10 MHRA Products search for kisspeptin, 5 October 2026The exact name returns 5 MHRA Products documents that mention it in their text; none was assessed as a product with it as an active substance
WADA
Named in a prohibited class 11 WADA Prohibited List 2026S2.2.1: names kisspeptin; the list text reads kisspeptin and its agonist analogues
European Union: EMA records
EU
- No centrally authorised procedure in the EMA medicines data of 5 Oct 2026 names kisspeptin as an active substance. National authorisations are not in that dataset. Source sentence
EMA medicines JSON report, snapshot 2026-10-05T06:02:03Z: 0 procedures for kisspeptin; control lookup (semaglutide): 5 procedures.
8 EMA medicines data, 5 October 2026
United Kingdom: MHRA records
UK
- The exact name kisspeptin returns 5 MHRA Products documents on 5 Oct 2026. They mention the name in their text and were not assessed as products with it as an active substance. Source sentence
MHRA Products search for the exact name "kisspeptin" over SmPC, PIL and PAR documents: 5 documents; control lookup (semaglutide): 271 documents.
10 MHRA Products search for kisspeptin, 5 October 2026
Sport anti-doping list
International
- The WADA 2026 Prohibited List, in force from 1 Jan 2026, names kisspeptin under S2.2.1. A WADA entry is a sporting rule, not a statement about legality outside sport. Source sentence
• kisspeptin and its agonist analogues; section S2.2.1: Testosterone-stimulating peptides in males including, but not limited to:
11 WADA Prohibited List 2026
Registry records
- On 5 Oct 2026 ClinicalTrials.gov listed 5 registered studies for the names kisspeptin-10 and kisspeptin 10, all of them interventional. Phases as registered: PHASE3 (3), PHASE1 (2). Lead sponsors as registered: Quaid-e-Azam University (2); Stephanie B. Seminara, MD (1); Massachusetts General Hospital (1). Source sentence
query.intr kisspeptin-10 or kisspeptin 10: registered 5, interventional 5, phases {"PHASE3": 3, "PHASE1": 2}, lead sponsors Quaid-e-Azam University (2); Stephanie B. Seminara, MD (1); Massachusetts General Hospital (1).
12 ClinicalTrials.gov search for Kisspeptin-10, 5 October 2026
Integrity notes
- The PubMed records read for the four studies on this page list no correction, retraction or expression of concern (checked 5 Oct 2026). Source sentence
PubMed efetch CommentsCorrections for PMIDs 11457843, 11385580, 11387329 and 14573733: none of type ErratumIn, RetractionIn or ExpressionOfConcernIn.
9 PubMed search for Kisspeptin-10, 5 October 2026
Other compounds in the Academy
Chemistry and records
Kisspeptin-10: sequence, mass, CAS and regulatory record in the research library →
Sources
- 1PubChem CID 25240297 accessed 5 Oct 2026
- 2Peptency catalog chemistry record, Kisspeptin-10 accessed 5 Oct 2026
- 3J Biol Chem 2001 accessed 5 Oct 2026
- 4Nature 2001 accessed 5 Oct 2026
- 5J Biol Chem 2001 accessed 5 Oct 2026
- 6N Engl J Med 2003 accessed 5 Oct 2026
- 7openFDA Drugs@FDA query for kisspeptin and metastin, 5 October 2026 accessed 5 Oct 2026
- 8EMA medicines data, 5 October 2026 accessed 5 Oct 2026
- 9PubMed search for Kisspeptin-10, 5 October 2026 accessed 5 Oct 2026
- 10MHRA Products search for kisspeptin, 5 October 2026 accessed 5 Oct 2026
- 11WADA Prohibited List 2026 accessed 5 Oct 2026
- 12ClinicalTrials.gov search for Kisspeptin-10, 5 October 2026 accessed 5 Oct 2026
About this page
Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.
Drafted from the verified research library records and passed the Academy schema, cross reference and wording checks. The seven checker rounds used on the earlier compound pages have not been run on this page.. Version 1, edited 16 November 2026, 12 sources.
Cite this page: Peptency Academy. Kisspeptin-10: sequence, studies and status. Version 1./eu/academy/compounds/kisspeptin-10/